Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin

Journal of Hepatology

Volumn 39, Issue 5, 2003, Pages 875-878

  Tang, Sydney ^a,b   Cheng, Ignatius K P ^a   Leung, Vincent K S ^b   Kuok, Un I ^a   Tang, Anthony W C ^b   Ho, Yiu Wing ^b   Lai, Kar Neng ^a   Chan, Tak Mao ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Hepatitis C; Interferon; Kidney transplantation; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; CREATININE; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG RESPONSE; GENOTYPE; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; MALE; PATIENT SELECTION; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

EID: 0242521535     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00358-1     Document Type: Article

References (18)

1. Vosnides GG, Hepatitis C. in renal transplantation. Kidney Int 1997;52:843-861.
2. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991;325:454-460.
3. Izopet J, Rostaing L, Sandres K, Cisterne JM, Pasquier C, Rumeau JL, et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000;181:852-858.
4. McHutchison JG, Gordon SC, Schiff ER, Shiftman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-1492.
5. Magnone M, Holley JL, Shapiro R, Scantlebury V, McCauley J, Jordan M, et al. Interferon-alpha-induced acute renal allograft rejection. Transplantation 1995;59:1068-1070.
6. Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996;74:512-516.
7. Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66:471-476.
8. Chan TM, Lok AS, Cheng IK, Chan RT. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993;104:862-868.
9. Chan TM, Lok AS, Cheng IK, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993;17:5-8.
10. Dalekos GN, Boumba DS, Katopodis K, Zervou E, Sferopoulos G, Elisaf M, et al. Absence of HCV viraemia in anti-HCV-negative haemodialysis patients. Nephrol Dial Transpl 1998;13:1804-1806.
11. Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452-1457.
12. Chan TM, Wu PC, Lok AS, Lai CL, Cheng IK. Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation. Nephron 1995;71:213-217.
13. Chan TM, Lok AS, Cheng IK, Ng IO. Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon. Transplantation 1993;56:1095-1098.
14. Fabrizi F, Poordad FF, Martin P, Hepatitis C. infection and the patient with end-stage renal disease. Hepatology 2002;36:3-10.
15. Chan TM, Lau JY, Lok AS, Lai CL, Cheng IK, Hepatitis C. virus genotypes in patients on renal replacement therapy. Nephrol Dial Transpl 1998;13:731-734.
16. Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998;160:3487-3493.
17. Jen J, Laughlin M, Chung C, Heft S, Affrime MB, Gupta SK, et al. Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models. Clin Pharmacol Ther 2002;72:349-361.
18. Bruchfeld A, Stahle L, Andersson J, Schvarcz R. Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection-a pilot study. J Viral Hepat 2001;8:287-292.